The effects of serum on the toxicity of manufactured nanoparticles

Toxicology Letters

Volumn 198, Issue 3, 2010, Pages 358-365

  Clift, Martin J D ^a,b   Bhattacharjee, Sourav ^a,c   Brown, David M ^a   Stone, Vicki ^a  

^a EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Cytotoxicity; Macrophages; Nanoparticles (NPs); Oxidative stress; Pro inflammatory cytokine stimulation; Serum

Indexed keywords

GLUTATHIONE; NANOPARTICLE; POLYSTYRENE; TUMOR NECROSIS FACTOR ALPHA; FORMAZAN; LACTATE DEHYDROGENASE; MTT FORMAZAN; TETRAZOLIUM;

ANIMAL CELL; ARTICLE; CARBOXYLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PRIORITY JOURNAL; SERUM; SUSPENSION; ANIMAL; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; TOXICITY;

ANIMALS; CELL LINE; CELL SURVIVAL; FORMAZANS; GLUTATHIONE; L-LACTATE DEHYDROGENASE; MACROPHAGES; MICE; NANOPARTICLES; OXIDATIVE STRESS; PARTICLE SIZE; SERUM; TETRAZOLIUM SALTS; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 80051483471     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.08.002     Document Type: Article

References (23)

1. Brown D.M., Wilson M.R., MacNee W., Stone V., Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol. 2001, 175:191-199.
2. Cedervall T., Lynch I., Lindman S., Berggård T., Thulin E., Nilsson H., Dawson K.A., Linse S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl. Acad. Sci. 2007, 104:2050-2055.
3. Clift M.J.D., Boyles M.S.P., Brown D.M., Stone V. An investigation into the potential for different surface coated quantum dots to cause oxidative stress and affect macrophage cell signalling in vitro. Nanotoxicology 2010, 4:139-149.
4. Clift M.J.D., Brown D.M., Rothen-Ruthishauser B., Duffin R., Donaldson K., Proudfoot L., Guy K., Stone V. Comparing a panel of commercially available quantum dots and polystyrene nanoparticles with differing surface characteristics; an analysis of their uptake and toxicity in a murine macrophage cell line. Toxicol. Appl. Pharmacol. 2008, 232:418-427.
5. Clift, M.J.D., Brown, D.M., Brandenberger, C., Byrne, G., Snjezana Stolnik-Trenkic, S.S., Rothen-Rutishauser, B., Stone, V., under review. The uptake and intracellular fate of a series of different surface coated quantum dots in vitro. Langmuir.
6. Duffin R., Tran C.L., Clouter A., Brown D.M., MacNee W., Stone V., Donaldson K. The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Ann. Occup. Hyg. 2002, 46:242-245.
7. Duffin R., Tran L., Brown D., Stone V., Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal. Toxicol. 2007, 19:849-856.
8. Ferin J., Oberdorster G., Penney D.P. Pulmonary retention of ultrafine and fine particles in rats. Am. J. Respir. Cell Mol. Biol. 1992, 6:535-542.
9. Foucaud L., Wilson M.R., Brown D.M., Stone V. Measurement of reactive species production by nanoparticles prepared in biologically relevant media. Toxicol. Lett. 2007, 174:1-9.
10. Geiser M., Rothen-Rutishauser B., Kapp N., Schurch S., Kreyling W., Schulz H., Semmler M., Hof V.I., Heyder J., Gehr P. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ. Health Perspect. 2005, 113:1555-1560.
11. International Standards Organisation (ISO) Technical Specification (ISO/TS) 27687; Nanotechnologies - Terminology and definitions for nano-objects - Nanoparticle, nanofibre and nanoplate; First published 2008-08-15.
12. Johnston H.J., Semmler-Behnke M., Brown D.M., Kreyling W., Tran L., Stone V. Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro. Toxicol. Appl. Pharmacol. 2010, 242:66-78.
13. Lovric J., Bazzi H.S., Cuie Y., Fortin G.R.A., Winnik F.M., Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J. Mol. Med. 2005, 83:377-385.
14. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Soc. 2008, 105:14265-14270.
15. Maynard A.D. Nanotechnology: the next big thing, or much ado about nothing?. Ann. Occup. Hyg. 2007, 51:1-12.
16. Maynard A.D., Aitken R.J., Butz T., Colvin V., Donaldson K., Oberdorster G., Philbert M.A., Ryan J., Seaton A., Stone V. Safe handling of nanotechnology. Nature 2006, 444:267-269.
17. Oberdorster G., Ferin J., Morrow P.E. Volumetric loading of alveolar macrophages (AM): a possible basis for diminished AM-mediated particle clearance. Exp. Lung Res. 1992, 18:87-104.
18. Oberdorster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2005, 2:8.
19. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
20. Oberdorster G., Stone V., Donaldson K. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 2007, 1:2-25.
21. Petri-Fink A., Steitz B., Finka A., Salaklang J., Hofman H. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies. Eur. J. Pharm. Biopharm. 2008, 68:129-137.
22. Stoppiglia L.F., Nogueira T.A., Leite A.R., Carneiro E.M., Boschero A.C. Protective effect of d-glucose, l-leucine and fetal calf serum against oxidative stress neonatal pancreatic islets. Biochem. Biophys. Acta 2002, 1588:113-118.
23. Takeda T., Akao M., Matsumoto-Ida M., Takenaka H., Kihara Y., Kume T., Akaike A., Kita T. Serofendic acid, a novel substance extracted from fetal calf serum, protects against oxidative stress in neonatal rat cardiac myocytes. J. Am. Coll. Cardiol. 2006, 47:1882-1890.